Delivery Order SPE2DB20D2014-SPE2DB24FB47A

Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $8.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price and has a ceiling value of $1,159.97. The contract has an ultimate completion date of January 30, 2025. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $10,756.24 and a completion date of May 6, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of UBRELVY 100 MG TABLET UD 10S to the government. The $4,981.17 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of UBRELVY 50 MG TABLET UD 10S to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $8,266.36, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of UBRELVY 100 MG TABLET UD 10S. The contract has an award value of $1,528.07 and a completion date of June 11, 2024. The contract is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,671.56, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, on May 13, 2024, with a completion date of May 14, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $4,152.95 and an ultimate completion date of February 18, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside....
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S medication to the U.S. Defense Logistics Agency (DLA). The $2,533.77 firm-fixed-price contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a completion date of July 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,308.01 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 10S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $3,896.54, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This is a firm fixed-price delivery order contract with a completion date of July 26, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB47A
    Delivery Order

This federal contract award is for the delivery of UBRELVY 100 MG TABLET UD 16S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $8,213.48 and a performance period through April 1, 2024. No set-aside designation was used for this award. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense's military treatment programs and medical facilities worldwide.

Generated 6/28/24, 9:28 AM